Skip to main content

Table 1 Baseline characteristics of the patients (N = 1660)

From: Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction

Characteristic n (% of total)*
Gender
   Male 1183 (71.3%)
   Female 430 (25.9%)
   Not specified 47 (2.8%)
Ethnicity
   White 1116 (67.2%)
   Mestizo 300 (18.1%)
   Black 154 (9.3%)
   Chinese 8 (0.5%)
   Not specified 82 (4.9%)
Age (yr) total (183 not specified) 61.6 ± 13.0
Onset-infusion time (hours) 4.9 ± 3.7
Previous SK
   < 1 year 5 (0.3%)
   > 1 year 9 (0.5%)
Concomitant therapy
   Aspirin 1341 (80.8%)
   Beta-blockers 943 (56.8%)
   Nitrosorbide 258 (15.5%)
   Lidocaine 66 (3.9%)
   Pentaerythritol tetranitrate 45 (2.7%)
   Others 641 (38.6%)
  1. *Continuous variables are presented as Mean ± SD